BHCM
ZYME icon

Brevan Howard Capital Management’s Zymeworks ZYME Stock Holding History

Brevan Howard Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,333
Closed -$614K – 2557
2025
Q4 		$614K Buy
23,333
+8,815
+61% +$192K 0.01% 1000
2025
Q3 		$248K Buy
14,518
+3,890
+37% +$55.7K ﹤0.01% 1659
2025
Q2 		$133K Buy
+10,628
New +$127K ﹤0.01% 1767

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Brevan Howard Capital Management's ZYME Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 23,333 shares — an estimated $614K sold.

Brevan Howard Capital Management first reported a position in ZYME in Q2 2025 and held it in 3 quarters. The position peaked at $614K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 23,333 Zymeworks shares in Q1 2026, an estimated $614K.
  • Brevan Howard Capital Management first reported a position in Zymeworks in Q2 2025 and held it in 3 quarters.
  • Brevan Howard Capital Management's Zymeworks position peaked at $614K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.